Viewing Study NCT00734435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-06-02 @ 7:44 AM
Study NCT ID: NCT00734435
Status: TERMINATED
Last Update Posted: 2012-11-29
First Post: 2008-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
Sponsor: Orexigen Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Schizoaffective Disorder View
None Schizophreniform Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None schizophrenia View
None schizophreniform View
None schizoaffective disorder View
None Zyprexa View
None olanzapine View